Malignant Pleural Mesothelioma is a Highly Aggressive and Challenging Cancer
Malignant Pleural Mesothelioma is a Highly Aggressive and Challenging Cancer
One interesting study is called, "Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity" Biochimie Volume 81, Issue 7, July 1999, Pages 733-744 by Alexandra Syrokoua, George N. Tzanakakisb, Anders Hjerpeb and Nikos K. Karamanosa - Department of Chemistry, University of Patras, 261 10 Patras, Greece. Here is an excerpt: "Abstract - Identification of proteoglycans in two human malignant mesothelioma cell lines, one with epithelial differentiation and the other with fibroblast-like phenotype, and the effects of epidermal (EGF), insulin-like (IGF-I) and platelet-derived (PDGF-BB) growth factors on the synthesis of hyaluronan (HA) and proteoglycans (PGs) were studied. Both cell lines synthesize HA and PGs: these last were recovered both as secreted and cell-associated compounds. Chondroitin sulfate (CS) containing PGs are mainly organized as versican in the extracellular medium and as thrombomodulin and syndecan in the cell membrane. Heparan sulfate (HS) containing PGs are mainly in the form of perlecan in the culture medium, whereas cell-associated HSPGs were recovered mainly as syndecan-1, -2 and -4. Receptors for EGF, IGF-I and PDGF-BB were identified in both cell lines. In addition to cell proliferation, these growth factors stimulated the synthesis of HA and PGs, the pattern of stimulation being unique for each of them and depending on the cell phenotype. EGF increased the synthesis of HA and PGs. IGF-I showed similar stimulatory effects on the synthesis of CSPGs, whereas higher amounts were needed to influence the synthesis of HA and HSPGs, the latter only being stimulated in the epithelial cell line. PDGF-BB stimulated the synthesis of HA, HSPGs and CSPGs at low concentrations, while the stimulatory effect was abolished at higher levels. Incubation with genistein inhibited the HA and PG synthesis induced by growth factors in a mode depending on both growth factor and genistein concentrations. The results clearly suggest that the stimulatory effects of EGF, IGF-I and PDGF-BB on matrix synthesis, expressed as proteoglycan synthesis, are mediated via receptor-growth factor complexes and the protein tyrosine kinase intracellular pathway.
Another study is called, "Wnt2 as a new therapeutic target in malignant pleural Mesothelioma" by Julien Mazieres, Liang You, Biao He, Zhidong Xu, Sarah Twogood, Amie Y. Lee, Noemi Reguart, Sonny Batra, Iwao Mikami, David M. Jablons, - International Journal of Cancer - Volume 117, Issue 2, pages 326332, 1 November 2005. Here is an excerpt: "Malignant mesothelioma of the pleura (MPM) is a highly aggressive neoplasm with a poor prognosis and limited treatment options. A better understanding of its pathogenesis is essential to developing alternative therapeutic strategies. We previously demonstrated that the Wnt signaling pathway is activated in MPM through the overexpression of disheveled proteins. To extend our knowledge of Wnt signaling activation in MPM, we performed Wnt-specific microarrays in normal pleura and MPM. We found that the most common event in MPM was the upregulation of Wnt2. We inhibited Wnt2 by siRNA and a monoclonal anti-Wnt2 antibody and analyzed their effects on apoptosis and downstream signaling effectors. We then assessed the antiproliferative effects of the Wnt2 antibody and Alimta, one of the current standard treatments of MPM. We confirmed Wnt2 overexpression at the mRNA and protein level in MPM cell lines and tissues. We then demonstrated that inhibition of Wnt2 by siRNA or a monoclonal antibody induces programmed cell death in MPM cells. We next analyzed the effects of the anti-Wnt2 antibody and of Alimta on MPM cell proliferation. We found that although Wnt2 antibody by itself had less antiproliferative potency than Alimta, the two in combination had substantially more activity than Alimta alone. We thus propose that inhibition of Wnt2 is of therapeutic interest in the development of more effective treatments for MPM. 2005 Wiley-Liss, Inc.
Malignant pleural mesothelioma (MPM) is a highly aggressive and challenging cancer arising primarily from the pleural lining of the lung. Approximately 3,000 patients are diagnosed with MPM in the United States annually and the incidence of this tumor is predicted to increase dramatically over near term, peaking around 2020.1 Since MPM usually presents at an advanced stage, a curative resection is rarely possible. Radiotherapy has failed to show clinical benefit as a single treatment modality, and the administration of chemotherapy is mostly restricted to the advanced stage with limited efficiency.2 Alternative strategies based on pleural injections of recombinant cytokines have similarly proven unsatisfactory.3 Since current interventions offer only limited benefit and overall survival is low, there is an urgent need to develop new therapeutic agents based on a greater understanding of MPM's underlying molecular mechanisms.
The Wnt family of secreted glycoproteins is a group of signaling molecules broadly involved in developmental processes and oncogenesis.4, 5 Nineteen human Wnt proteins have thus far been identified. Transduction of Wnt signals is triggered by the binding of Wnt ligands to 2 distinct families of cell-surface receptors: the frizzled (Fz) receptor family and the LDL-receptor-related protein (LRP) family.6 Intracellularly, Wnt signaling activates disheveled (Dvl) proteins, which inhibit glycogen synthase kinase-3 (GSK-3) phosphorylation of -catenin, leading to its cytosolic stabilization. Stabilized -catenin then enters the cell nucleus and associates with LEF/TCF transcription factors. -catenin-Tcf/Lef induces transcription of important downstream target genes, many of which have been implicated in cancer.
If you found any of these excerpts interesting, please read the studies in their entirety.
Mesothelioma and Cancer Gene Therapy Treatment for Erectile Dysfunction Due to Over Masturbation When Doctors Do Not Follow Up After Psa Results Indicate The Possibility Of Prostate Cancer Why Ignoring Signs Of Colon Cancer May Lead To A Malpractice Claim By Not Following The Colon Cancer Screening Guidelines A Doctor May Delay Your Diagnosis Sinus Tachycardia Treatment Male Pattern Baldness Treatments Is Now Done Successfully With Finasteride Cancer Defeated About Index2 The Diagnosis And Treatment Of Prostate Cancer Dark Circles Treatment And Remove Dark Circles Naturally Breast Cancer Awareness Pt. 3: Breast Cancer Biopsy Defining Angioedema Treatment NLP & Hypnosis Phobia Treatment For Fear of Flying